Articles by Thomas Bollyky
The Global Burden of Disease (GBD) Study is the most ambitious effort to date to quantify the world’s health status. Involving 486 collaborators from 302 institutions in 50 countries, the study has been compared to the Human Genome Project in terms of potential impact. But health experts have criticized it as nontransparent and lacking accountability. What role will the GBD Study play in global health policymaking - and how can it be improved?